News
12d
GlobalData on MSNNICE issues positive guidance for pulsed field ablation in AF treatmentThe UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation ...
Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes treatment of drug refractory, symptomatic persistent atrial fibrillation.The ...
Dr Segal said there are a number of symptoms to be aware of. He said: "Symptoms can vary but often include palpitations (a ...
The benefit seems durable, but one expert says patients should be aware there’s “some risk of stroke” during the procedure.
Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible for treatment with the Farapulse pulsed field ablation system.
“An arrhythmia is a problem with the heart’s electrical system, which controls how the heart beats,” explains Segal.
Boston Scientific (NYSE: BSX) announced today that NICE issued guidance supporting the use of pulsed field ablation (PFA) for treating AFib.
It’s important to notify a doctor if you experience regular palpitations and/or dizziness, especially if they are accompanied by other symptoms.
Marlborough: Boston Scientific Corporation has announced that the company has received approval from the U.S. Food and Drug ...
Boston Scientific (NYSE: BSX) announced that the FDA approved an expansion to the label of its Farapulse pulsed field ablation (PFA) system.
Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...
New meta-analysis finds oral anticoagulants reduce net adverse events in patients with atrial fibrillation after intracranial hemorrhage but with a higher risk for recurrent intracranial hemorrhage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results